Francoise Sarrot-Reynauld
Overview
Explore the profile of Francoise Sarrot-Reynauld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
697
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dernoncourt A, Guettrot-Imbert G, Sentilhes L, Besse M, Molto A, Queyrel-Moranne V, et al.
BJOG
. 2024 Dec;
132(5):614-624.
PMID: 39702994
Objective: To assess safety of fertility treatments in women with systemic lupus erythematosus (SLE). Design: Data from the multicentre French observational GR2 (Groupe de Recherche sur la Grossesse et les...
2.
Belbezier A, Nguyen T, Arnaud M, Ducotterd B, Vangout M, Deroux A, et al.
J Transl Autoimmun
. 2024 Mar;
8:100238.
PMID: 38496268
Sjögren's syndrome (SS) is a systemic autoimmune pathology manifested mainly by a dry syndrome, intense asthenia and arthromyalgia. Systemic manifestations may also occur. Since 2019, immunosuppressant agents (IS) or biotherapies...
3.
Murarasu A, Guettrot-Imbert G, Le Guern V, Yelnik C, Queyrel V, Schleinitz N, et al.
Lancet Rheumatol
. 2024 Jan;
4(12):e842-e852.
PMID: 38261392
Background: Prospective data about the risks of thrombotic and severe haemorrhagic complications during pregnancy and post partum are unavailable for women with antiphospholipid syndrome. We aimed to assess thrombotic and...
4.
Martin de Fremont G, Costedoat-Chalumeau N, Lazaro E, Belkhir R, Guettrot-Imbert G, Morel N, et al.
Lancet Rheumatol
. 2024 Jan;
5(6):e330-e340.
PMID: 38251600
Background: Adverse pregnancy outcomes in women with primary Sjögren's syndrome have only been evaluated retrospectively using heterogeneous methods and with contradictory results. We aimed to describe adverse pregnancy, delivery, and...
5.
Le Voyer T, Parent A, Liu X, Cederholm A, Gervais A, Rosain J, et al.
Nature
. 2023 Nov;
623(7988):803-813.
PMID: 37938781
Patients with autoimmune polyendocrinopathy syndrome type 1 (APS-1) caused by autosomal recessive AIRE deficiency produce autoantibodies that neutralize type I interferons (IFNs), conferring a predisposition to life-threatening COVID-19 pneumonia. Here...
6.
Riller Q, Fourgeaud J, Bruneau J, de Ravin S, Smith G, Fusaro M, et al.
J Allergy Clin Immunol
. 2023 Jan;
151(6):1634-1645.
PMID: 36638922
Background: Allogenic hematopoietic stem cell transplantation (HSCT) and gene therapy (GT) are potentially curative treatments for severe combined immunodeficiency (SCID). Late-onset posttreatment manifestations (such as persistent hepatitis) are not uncommon....
7.
Cheminant M, Fox T, Alligon M, Bouaziz O, Neven B, Moshous D, et al.
Blood
. 2022 Sep;
141(1):60-71.
PMID: 36167031
Allogeneic hematopoietic stem cell transplantation (alloSCT) is curative for severe inborn errors of immunity (IEIs), with recent data suggesting alloSCT in adulthood is safe and effective in selected patients. However,...
8.
Jourde-Chiche N, Costedoat-Chalumeau N, Baumstarck K, Loundou A, Bouillet L, Burtey S, et al.
Ann Rheum Dis
. 2022 Jun;
81(10):1420-1427.
PMID: 35725295
Objectives: Lupus nephritis (LN) is a frequent complication of systemic lupus erythematosus (SLE). Severe (proliferative) forms of LN are treated with induction immunosuppressive therapy (IST), followed by maintenance IST, to...
9.
David C, Costedoat-Chalumeau N, Belhadi D, Laouenan C, Boutten A, Chezel J, et al.
J Intern Med
. 2022 Apr;
292(3):536-539.
PMID: 35373869
No abstract available.
10.
David C, Duployez N, Eloy P, Belhadi D, Chezel J, Le Guern V, et al.
Rheumatology (Oxford)
. 2022 Feb;
61(11):4355-4363.
PMID: 35176141
Objective: The detection of somatic mutations among the genes of myeloid cells in asymptomatic patients-defining clonal haematopoiesis of indeterminate potential (CHIP)-is associated with a predisposition to cardiovascular events (CVEs) in...